AV indicates atrioventricular; ICD, implantable cardioverter-defibrillator; IHD, ischemic heart disease; NSVT, nonsustained ventricular tachycardia;
This article includes the revised recommendation that providers may consider either amiodarone or lidocaine to treat shock
Introduction Ventricular arrhythmias (VAs) including ventricular tachycardia (VT) and ventricular fibrillation (VF) can be life-threatening and can
1-3 week IV infusion: 600-800 mg/day >3 week IV infusion: 400 mg/day Next: Interactions Enter a drug name and amiodarone All Interactions Sort By: Contraindicated (27)
[4] This includes ventricular tachycardia (VT), ventricular
Generally doses of 200 to 400 mg/d have been used during long-term therapy of supraventricular and ventricular arrhythmia, but doses as low as 100 mg/d have been
It can be used for paroxysmal supraventricular, nodal and ventricular tachycardias, atrial fibrillation and flutter, and ventricular fibrillation
Nonsustained ventricular tachycardia (NSVT) is a common but poorly understood arrhythmia
5-1 mg/min hypotension, heart block, Dosages given in the table may differ from those recommended by the manufacturers
This activity reviews the indications, action, and contraindications for procainamide as a valuable
41 In patients known to have severely impaired heart function, IV amiodarone is preferable to other antiarrhythmic agents for atrial and ventricular arrhythmias
Historically, lidocaine, amiodarone, procainamide, and sotalol have been used for Half-Life Elimination
Monitor peripheral site closely and document Infiltration and Phlebitis scale Q1H
Local Injectable Anesthesia: Maximum individual dose: 4 mg/kg (IV regional anesthesia); 4
The Amiodarone in Out-of-Hospital Resuscitation of Refractory Sustained Ventricular Tachycardia (ARREST)
Continuous infusion of 1 mg/min via IV for 6 hours, 0
Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
Amiodarone
Amiodarone is an effective antiarrhythmic medication frequently used in practice for both ventricular and atrial arrhythmias
Patients with stable ventricular tachycardia should be given 150 mg of amiodarone intravenously over 10 minutes, followed by an infusion at 1 mg per minute for six hours and then at 0
Dosage reduction recommended in patients
5 mg/min drip over next 18 hrs (540 mg total) Oral dosage after IV infusion is 400 -800 mg PO The rate of recurrent ventricular tachycardia was 15 to 44% lower among patients receiving sotalol than among those receiving either placebo or beta-blockers alone